These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19173204)

  • 1. [Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer].
    Santos-García D; Prieto JM; Lema M
    Rev Neurol; 2009 Jan 16-31; 48(2):71-4. PubMed ID: 19173204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parotid gland metastasis of a breast cancer.
    Perez-Fidalgo JA; Chirivella I; Laforga J; Colio JM; Blanes MD; Baydal R; Roselló S; De-la-Morena E; Lluch A
    Clin Transl Oncol; 2007 Apr; 9(4):264-5. PubMed ID: 17462982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Ganz PA; Cecchini RS; Julian TB; Margolese RG; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):857-65. PubMed ID: 26686960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.
    Tutuncu M; Demirci NO; Özer F; Saip S; Kantarci OH; Siva A
    Mult Scler; 2011 Oct; 17(10):1262-4. PubMed ID: 21135019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
    Le Page E; Leray E; Taurin G; Coustans M; Chaperon J; Morrissey SP; Edan G
    J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):52-6. PubMed ID: 17846110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
    Reggio E; Nicoletti A; Fiorilla T; Politi G; Reggio A; Patti F
    J Neurol; 2005 Oct; 252(10):1255-61. PubMed ID: 15940386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 9. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
    Zivadinov R; Dwyer MG; Hussein S; Carl E; Kennedy C; Andrews M; Hojnacki D; Heininen-Brown M; Willis L; Cherneva M; Bergsland N; Weinstock-Guttman B
    Mult Scler; 2012 Aug; 18(8):1125-34. PubMed ID: 22194217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes insipidus revealing an isolated pituitary stalk metastasis of breast cancer.
    Lin CS; Lin SH; Chiang YH; Sheu LF; Chao TY
    Eur J Neurol; 2007 Jul; 14(7):e11-2. PubMed ID: 17594304
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice.
    Antolín-Novoa S; Blanco-Campanario E; Antón A; Gallegos-Sancho MI; Pérez-Carrión R; Peláez I; Galán-Brotons A; de la Cruz-Merino L; Murías-Rosales A;
    Clin Transl Oncol; 2015 Nov; 17(11):862-9. PubMed ID: 26103952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. t(8;16) AML developed subsequent to breast cancer therapy.
    Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
    Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.
    Turner B; Lin X; Calmon G; Roberts N; Blumhardt LD
    Mult Scler; 2003 Feb; 9(1):21-7. PubMed ID: 12617263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of adriamycin in the treatment of metastatic breast cancer].
    Dymarskiĭ LIu; Sanchakova AV; Aleksandrova GI; Trishkina EA
    Vopr Onkol; 1984; 30(6):67-73. PubMed ID: 6547554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-intensive therapy for breast cancer.
    O'Shaughnessy JA; Cowan KH
    JAMA; 1993 Nov; 270(17):2089-92. PubMed ID: 8411576
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.
    McCormack PL; Scott LJ
    CNS Drugs; 2004; 18(8):521-46. PubMed ID: 15182221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
    Wynn D; Kaufman M; Montalban X; Vollmer T; Simon J; Elkins J; O'Neill G; Neyer L; Sheridan J; Wang C; Fong A; Rose JW;
    Lancet Neurol; 2010 Apr; 9(4):381-90. PubMed ID: 20163990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
    Di Lauro L; Vici P; Del Medico P; Laudadio L; Tomao S; Giannarelli D; Pizzuti L; Sergi D; Barba M; Maugeri-Saccà M
    Breast Cancer Res Treat; 2013 Aug; 141(1):119-23. PubMed ID: 23982884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in locally advanced breast cancer.
    Singh G; Singh DP; Gupta D; Muralikrishna BV
    J Surg Oncol; 1996 Jan; 61(1):38-41. PubMed ID: 8544458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
    Sormani MP; Stubinski B; Cornelisse P; Rocak S; Li D; De Stefano N
    Mult Scler; 2011 May; 17(5):541-9. PubMed ID: 21148262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.